FY2025 · period end Dec '25 · from the 10-K filed Mar 2, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B |
| Gross Profit | $396.91B | $353.58B | $332.85B | $290.46B | $256.56B |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B |
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B |
| Capital Expenditures | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 88.7% | 88.3% | 89.6% | 89.6% | 89.2% |
| Operating Margin | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 12.2% | 15.0% | 25.5% | 25.7% | 24.1% |
| Return on Assets | 4.0% | 5.0% | 8.6% | 8.8% | 8.4% |
| Debt / Equity | 0.73× | 0.73× | 0.62× | 0.68× | 0.60× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000731766-26-000191 | Jul 16, 2026 | Jul 16, 2026 | Jul 16, 2026 10:00 UTC | EDGAR |
| 8-K | 0000731766-26-000138 | Jun 1, 2026 | Jun 5, 2026 | Jun 5, 2026 20:17 UTC | EDGAR |
| 8-K | 0000731766-26-000129 | May 11, 2026 | May 11, 2026 | May 11, 2026 21:28 UTC | EDGAR |
| 10-Q | 0000731766-26-000127 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 20:38 UTC | EDGAR |
| 8-K | 0000731766-26-000121 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 10:02 UTC | EDGAR |
| 8-K | 0000731766-26-000067 | Mar 9, 2026 | Mar 9, 2026 | Mar 9, 2026 20:33 UTC | EDGAR |
| 10-K | 0000731766-26-000062 | Dec 31, 2025 | Mar 2, 2026 | Mar 2, 2026 11:06 UTC | EDGAR |
| 8-K | 0000731766-26-000064 | Feb 24, 2026 | Mar 2, 2026 | Mar 2, 2026 14:21 UTC | EDGAR |
Direct links to SEC EDGAR. UNH has additional filings available on the SEC site.
6 numbers UNITEDHEALTH GROUP INC later changed — same XBRL tag, both filings linked.
Cost of Goods Sold (Deprecated 2018-01-31)·FY 2013
Minor restatementwas$2.8B
Revised up in a 10-K.
Cost of Goods Sold (Deprecated 2018-01-31)·Q1 2015
Minor restatementwas$1.1B
Revised up in a 10-Q.
Cost of Goods Sold (Deprecated 2018-01-31)·Q2 2015
Minor restatementwas$1.1B
Revised up in a 10-Q.
Cost of Goods Sold (Deprecated 2018-01-31)·FY 2014
Minor restatementwas$3.8B
Revised up in a 10-K.
Long-term Debt, Excluding Current Maturities·As of Dec 31, 2015
Minor restatementwas$25.5B
Revised down in a 10-K.
Accounts Receivable, Allowance for Credit Loss, Current·As of Dec 31, 2010
Major restatementwas$66M
Revised up in a 10-K.
UNH is not the only one.
See every restatement we've found across the market — or get an alert the next time UNH revises a number.
Restatements are detected by comparing every vintage of a fact across all of UNITEDHEALTH GROUP INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows UNH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling UNITEDHEALTH GROUP INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on UNH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on UNH and publish the result to your public profile.
Ask about UNITEDHEALTH GROUP INC
Continue in Workspace — cited answers on UNH, a thesis you can score, or an alert on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs